Skip to content
10-Q

Quarterly Report

ZS Pharma, Inc.

0001193125-15-181977

← back to feed
Filed
May 11, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 8, 2015 24.99M sh
Capex Q1 2015 · Mar 31, 2015 $869K
Capex Q1 2015 · Mar 31, 2014 $1.06M
Long Term Debt Q1 2015 · Mar 31, 2015 $10.03M
Long Term Debt Q1 2015 · Dec 31, 2014 $9.96M
Short Term Investments Q1 2015 · Mar 31, 2015 $46.22M
Short Term Investments Q1 2015 · Dec 31, 2014 $54.88M
Cash And Equivalents Q1 2015 · Mar 31, 2015 $213.39M
Cash And Equivalents Q1 2015 · Dec 31, 2014 $47.4M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $23.83M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $9.17M
Stockholders Equity Q1 2015 · Mar 31, 2015 $250.9M
Stockholders Equity Q1 2015 · Dec 31, 2014 $96.77M
Current Liabilities Q1 2015 · Mar 31, 2015 $12.32M
Current Liabilities Q1 2015 · Dec 31, 2014 $9.14M
Total Liabilities Q1 2015 · Mar 31, 2015 $22.55M
Total Liabilities Q1 2015 · Dec 31, 2014 $19.39M
Current Assets Q1 2015 · Mar 31, 2015 $260.33M
Current Assets Q1 2015 · Dec 31, 2014 $103.26M
Total Assets Q1 2015 · Mar 31, 2015 $273.45M
Total Assets Q1 2015 · Dec 31, 2014 $116.16M
Rd Expense Q1 2015 · Mar 31, 2015 $15.32M
Rd Expense Q1 2015 · Mar 31, 2014 $6.85M
Net Income Q1 2015 · Mar 31, 2015 −$21.95M
Net Income Q1 2015 · Mar 31, 2014 −$10.75M
Operating Income Q1 2015 · Mar 31, 2015 −$21.72M
Operating Income Q1 2015 · Mar 31, 2014 −$9.28M